Table 3.
Site and assessment of appropriateness for both treatment and prophylactic antibiotic regimens
| Site | Appropriate, n (%) | Inappropriate, n (%) | Not assessed, n (%) |
|---|---|---|---|
| Treatment | |||
| abdominal | 40/60 (66.7) | 16/60 (26.7) | 4/60 (6.7) |
| CNS | 4/6 (66.7) | 2/6 (33.3) | 0/6 (0) |
| dental | 9/26 (34.6) | 16/26 (61.5) | 1/26 (3.8) |
| ear/nose/throat | 44/105 (41.9) | 58/105 (55.2) | 3/105 (2.9) |
| gynaecological | 23/32 (71.9) | 7/32 (21.9) | 2/32 (6.2) |
| orthopaedic | 5/9 (55.6) | 2/9 (22.2) | 2/9 (22.2) |
| respiratory | 106/160 (66.3) | 52/160 (32.5) | 2/160 (1.3) |
| unknown source | 22/36 (61.1) | 11/36 (30.6) | 3/36 (8.3) |
| skin | 150/209 (71.8) | 54/209 (25.8) | 5/209 (2.4) |
| urinary | 119/159 (74.8) | 35/159 (22.0) | 5/159 (3.1) |
| other | 19/41 (46.3) | 18/41 (43.9) | 4/41 (9.8) |
| Prophylaxis | |||
| bite prophylaxis | 18/23 (78.3) | 5/23 (21.7) | 0/23 (0) |
| surgical prophylaxis | 5/9 (55.6) | 3/9 (33.3) | 1/9 (11.1) |
| wound prophylaxis | 65/118 (55.1) | 45/118 (38.1) | 8/118 (6.8) |
| other prophylaxis | 11/21 (52.4) | 9/21 (42.9) | 1/21 (4.8) |
| Unknown indication | 0/5 (0) | 0/5 (0) | 5/5 (100) |